TG Therapeutics (TGTX)
(Real Time Quote from BATS)
$21.29 USD
+0.06 (0.28%)
Updated Jul 19, 2024 10:16 AM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
TGTX 21.29 +0.06(0.28%)
Will TGTX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TGTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TGTX
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX)
TGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Company News for Feb 29, 2024
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates
Other News for TGTX
Nasdaq 100 Overbought? Here’s What History Says About The Current Rally
TG Therapeutics call volume above normal and directionally bullish
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
TG Therapeutics Shareholders Back Growth at Annual Meeting
Hold TG Therapeutics For Intriguing Outcomes